Evaluation of the Impact of Meibomian Gland Dysfunction Using a Novel Patient-Reported Outcome Instrument

Area of Science:

• Ophthalmology
• Ocular Surface Disease
• Patient-Reported Outcomes

Background:

• Meibomian gland dysfunction (MGD) is a common condition affecting the ocular surface.
• The impact of MGD on patients' quality of life requires comprehensive characterization.

Purpose of the Study:

• To evaluate the influence of Meibomian gland dysfunction (MGD) severity on patients' quality of life.
• To assess the reliability of the MGD Impact Questionnaire (MGD IQ) for measuring disease impact.

Main Methods:

• A prospective, multicenter, noninterventional study involving 75 participants aged 40+.
• Participants were categorized into non-MGD, mild/moderate MGD, and severe MGD cohorts.
• The MGD Impact Questionnaire (MGD IQ) was administered at two time points to assess intervisit agreement.

Main Results:

• Increasing MGD severity correlated with higher MGD IQ scores, indicating reduced quality of life.
• Severe MGD cohorts reported greater difficulties with reading, leisure activities, and eye care compared to mild/moderate MGD.
• Mild/moderate MGD cohorts experienced more difficulty with computer work than non-MGD individuals.

Conclusions:

• Meibomian gland dysfunction severity negatively impacts vision-related activities and overall quality of life.
• The MGD IQ is a valuable tool for quantifying MGD's impact and supporting patient-centered research.